Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

Inside a cancer research laboratory on the campus of Harvard Medical School, two dozen small jars with pink plastic lids sat on a metal counter. Inside these humble-looking jars is the core of Joan ...

SAN DIEGO--(BUSINESS WIRE)--Curebound, a philanthropic organization that fundraises and invests in innovative cancer research, awarded 17 grants in December for a total of $8.25 million in funding to ...

The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...

Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...

LOS ANGELES – Oct. 15, 2024 – Stand Up To Cancer® (SU2C) today announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including ...

As a projected 10,000 Mainers are diagnosed with cancer this year, the Maine Cancer Foundation has awarded $550,840 in grants to four organizations with initiatives to help cancer patients navigate ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. STATE — Maine Cancer Foundation recently awarded four capacity-building ...

The Rally Foundation for Childhood Cancer Research, founded by Dean Crowe, has provided $50.5 million in support to ...

Seven Maine organizations will share $316,000 grants from the Maine Cancer Foundation for cancer prevention efforts across the state. Cancer remains a leading cause of death in Maine, affecting ...